Chronic Obstructive Pulmonary Disease Airway Epithelial Cell-derived Extracellular Vesicles Spread Cellular
Justine V Devulder1, Jonathan R Baker1, Peter S Fenwick1
1National Heart and Lung Institute, Imperial College London, London, United Kingdom; and.
American Journal of Respiratory Cell and Molecular Biology
|January 21, 2025
Summary
Extracellular vesicles from chronic obstructive pulmonary disease (COPD) patients transfer microRNA-34a to healthy cells, inducing cellular senescence and accelerating lung aging. This mechanism explains COPD progression and associated comorbidities.
Area of Science:
- Pulmonary Medicine
- Cellular Biology
- Aging Research
Background:
- Chronic obstructive pulmonary disease (COPD) is linked to accelerated lung aging and senescent cell accumulation.
- Cellular senescence, driven by microRNA-34a (miR-34a) and suppressed sirtuin-1 (SIRT1), contributes to COPD progression.
- The spread of senescence, potentially via extracellular vesicles (EVs), is a key factor in COPD and its comorbidities.
Purpose of the Study:
- To investigate the role of extracellular vesicles (EVs) in spreading cellular senescence in COPD.
- To analyze the microRNA (miRNA) content of EVs from COPD patients and their effect on healthy cells.
- To elucidate the mechanism of senescence spread mediated by EVs in COPD.
Main Methods:
- Isolation of EVs from small airway epithelial cells (SAEC) of healthy donors and COPD patients.
- Culture of healthy SAEC with COPD-derived EVs to assess senescence markers (p21CIP1, SIRT1).
- Measurement of miR-34a levels in EVs and recipient cells; use of miR-34a antagomir to block effects.
Main Results:
- COPD SAEC produce EVs enriched with miR-34a.
- EVs from COPD patients induce senescence in healthy recipient SAEC.
- This senescence induction is mediated by miR-34a transfer, suppressing SIRT1 and increasing p21CIP1 and senescence-associated β-galactosidase.
Conclusions:
- Extracellular vesicles (EVs) mediate the spread of cellular senescence in COPD via selective transfer of miR-34a.
- This EV-mediated miR-34a transfer provides a mechanism for local disease progression and distant spread, contributing to comorbidities.
- Targeting miR-34a within EVs may offer a therapeutic strategy for COPD and age-related lung diseases.


